Login to Your Account

Financings Roundup

Monday, July 11, 2011
SpringLeaf Therapeutics Inc., of Boston, secured an additional $4 million in a second closing of its Series B financing from new investor Excel Venture Management, bringing the total round to $19 million. The company is developing a technology designed to expand the availability of biologic therapeutics.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription